Plants with genetically modified events combined by conventional breeding: An assessment of the need for additional regulatory data  by Pilacinski, W. et al.
Food and Chemical Toxicology 49 (2011) 1–7Contents lists available at ScienceDirect
Food and Chemical Toxicology
journal homepage: www.elsevier .com/locate / foodchemtoxReview
Plants with genetically modiﬁed events combined by conventional breeding:
An assessment of the need for additional regulatory data
W. Pilacinski a,⇑, A. Crawford b, R. Downey c, B. Harvey d, S. Huber e, P. Hunst f, L.K. Lahman b, S. MacIntosh g,
M. Pohl h, C. Rickard i, L. Tagliani j, N. Weber k
aAgbiotech Consultant, 524 Rosewell Ct., St. Louis, MO 63021, USA
bRegulatory Affairs, Monsanto Company, 800 N. Lindbergh Blvd., St. Louis, MO 63167, USA
cCanoglobal Consulting, Inc., 23 Simpson Cres., Saskatoon, Canada SK S7H 3C5
d Plant Sciences Department, University of Saskatchewan, 51 Campus Drive, Saskatoon SK, Canada S7N 5A8
e Syngenta Biotechnology, Inc., P.O. Box 12257, 3054 Cornwallis Road, Research Triangle Park, NC 27709, USA
fGlobal Regulatory Affairs, Bayer CropScience LP, 2 T.W. Alexander Dr., Research Triangle Park, NC 27709, USA
gMacIntosh and Associates, Inc., 1203 Hartford Ave., St. Paul, MN 55116, USA
hBASF Plant Science Company GmbH, Agricultural Center - LI 444, Carl-Bosch-Strasse 64, Limburgerhof 67117, Germany
iCropLife International A.I.S.B.L., 326 Avenue Louise, Box 351050, Brussels, Belgium
jDow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN 46268, USA
kDuPont Experimental Station, P.O. Box 80353, Wilmington, DE 19880, USAa r t i c l e i n f o
Article history:
Received 7 May 2010
Accepted 3 November 2010
Keywords:
Combined GM events
Combined events
GM event
Combined traits
GM trait
Stacked traits0278-6915  2010 Elsevier Ltd.
doi:10.1016/j.fct.2010.11.004
⇑ Corresponding author. Tel.: +1 636 256 8559.
E-mail address: wpilacinski@att.net (W. Pilacinski
Open access under CC BYa b s t r a c t
Crop varieties with multiple GM events combined by conventional breeding have become important in
global agriculture. The regulatory requirements in different countries for such products vary consider-
ably, placing an additional burden on regulatory agencies in countries where the submission of additional
data is required and delaying the introduction of innovative products to meet agricultural needs. The pro-
cess of conventional plant breeding has predictably provided safe food and feed products both histori-
cally and in the modern era of plant breeding. Thus, previously approved GM events that have been
combined by conventional plant breeding and contain GM traits that are not likely to interact in a manner
affecting safety should be considered to be as safe as their conventional counterparts. Such combined GM
event crop varieties should require little, if any, additional regulatory data to meet regulatory
requirements.
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-NC-ND license. 1. Introduction
Since ﬁrst commercialized in 1996, genetically modiﬁed (GM)
crops have established a record of food, feed and environmental
safety. From a food and feed safety perspective, they have demon-
strated to be at least as safe as products produced by conventional
Table 1
Global data requirements for combined GM events. The information below describes
2 W. Pilacinski et al. / Food and Chemical Toxicology 49 (2011) 1–7methods (Lemaux, 2008; Cockburn, 2002). From an environmental
perspective, they can have impacts that are substantially lower
than for conventionally produced products (Lemaux, 2009).
The GM crops that obtained early commercial success provided
herbicide tolerance or insect protection (e.g., MON-Ø4Ø32-6 soy
and SYN-BTØ11-1 maize), but generally did not combine these
beneﬁts in the same plant. The current trend, however, is to com-
bine or ‘stack’ two or more single GM events to provide growers
with a combination of traits that increase ﬂexibility and improve
performance. Most often, conventional plant breeding is used to
combine GM events and in the past several years, multiple new
combined GM event crops have been commercialized globally
(James, 2007; James, 2009).
Prior to commercialization, crops containing new GM events are
subject to stringent regulatory testing, and must satisfy require-
ments that are more demanding than those applied to crops devel-
oped through conventional breeding (Bradford et al., 2005; NRC,
2004). However, there currently is no global consensus for the reg-
ulation of crops with GM events that have been combined by con-
ventional breeding. Consequently, individual regulatory agencies
have devised their own requirements, and requested data packages
may range from minimal to extensive. Additional regulatory
requirements that are not based on science- and risk-based safety
concerns further lengthen the review process, place an additional
burden on regulatory agencies, and delay introducing innovative
products to the grower.
In this paper, the current regulatory landscape for combined
GM events is described. This is followed by a review of conven-
tional plant breeding as it relates to combined GM event products,
and a review of the safety assessment process applied to single GM
event products. Then, the safety of combined GM events is dis-
cussed, considering the safety of the process used to create them
as well as the results of additional data on combined GM events,
given that these are required by some countries. Finally, based
on the information described and reviewed, the scientiﬁc basis
for regulatory data required for combined GM event products is
evaluated and reasonable data requirements, consistent with this
scientiﬁc basis, are proposed.the current, though ﬂuid, status of data requirements and review complexity for
combined GM events globally. All countries base their review on the approved single
events. For those countries with additional data requirements (right side of table), the
amount of data and the complexity of the review process varies greatly. The relative
position in the table for any individual country requiring additional data (see
examples, lower, right) is not meant to indicate their position in the continuum of
relative data requirements. The European Union requirements for additional data
requirements and review complexity are signiﬁcantly higher than those in any other
countries.
Data requirements:
No additional data unless
potential to interact
Continuum of additional data and complexity
of review from:
 Minimum data (conﬁrm presence of traits/
lack of interaction)
 Additional data if potential to interact
 Minimum review complexity (short,
deﬁned review period)
(increasing data and
complexity of review)
to:
 Comprehensive dataset regardless of inter-
action potential (phenotypic characteriza-
tion, molecular characterization, protein
levels, morphology, nutritional
composition)
 Additional data if potential to interact
 Complex review (undeﬁned, protracted
review period)
Country or region:
United States,Canada,
Australia/NewZealand
Mexico, Colombia, Taiwan, Philippines, Japan,
South Korea, South Africa, European Union2. Deﬁnitions and scope
It is important to understand the difference between the terms
GM trait, GM event and GM crop as they are used in this paper. A
GM trait is a phenotypic characteristic expressed from DNA in-
serted into the plant genome during the transformation process.
A GM event is deﬁned by the insertion of DNA into the plant gen-
ome as a result of a single transformation process. Multiple DNA
sequences may be inserted during a single transformation process.
Thus, a single GM event may be characterized by the expression of
one or more GM traits. A GM crop is one that contains one or more
GM events, and phenotypically expresses one or more GM traits.
Combined GM trait products (also referred to as ‘stacks’ or
‘pyramids’ in the literature [De Schrijver et al., 2007]) may be
produced using two broad approaches: (1) by conventional plant
breeding, where parents with single GM events are bred to produce
progeny with the combined GM events; or, (2) by molecular-based
methods where two or more traits are simultaneously or sequen-
tially transformed into a recipient crop. There are multiple ways
by which the molecular-based methods can be employed to
produce a crop with multiple traits (Halpin, 2005; Taverniers
et al., 2008).
There are also important differences resulting from GM events
combined using conventional breeding compared to molecular-
based methods. Most importantly, using conventional breeding
to combine GM events does not involve the transformation pro-cess; does not insert additional DNA into the genome; and does
not modify the existing genomic DNA. Based on these criteria,
GM events combined through conventional breeding do not consti-
tute a new GM event. Similarly, a combined GM event product is
not considered a new genetically modiﬁed organism (GMO), as de-
ﬁned by EU Directive 2001/18/EC (EC, 2001), nor a new living mod-
iﬁed organism (LMO), as deﬁned in the Cartagena Protocol on
Biosafety (SCBD, 2000). Additionally, according to rules established
by the Organization for Economic Cooperation and Development
(OECD, 2006), each commercial transformation event is assigned
a nine-digit alphanumerical unique identiﬁer. However, a new crop
variety developed from GM events combined by conventional
breeding is not given a new nine-digit alphanumeric OECD unique
identiﬁer; rather, the single GM event identiﬁers are used together
to designate the combined GM event product.
This paper focuses on combined GM event products produced
through conventional plant breeding (hereafter referred to as
‘‘combined GM events’’), and is limited to GM events containing
genes that are not likely to interact in a manner affecting safety.
The discussion of trait interaction is complex. Traits that do not
interact function independently and do not exhibit synergism,
potentiation or antagonism. The GM events considered in this pa-
per are unlikely to interact in a manner that affects safety, as they
either, (a) do not share the same metabolic intermediates and are
not in the same metabolic pathway, or, (b) exhibit mechanisms of
action that are distinct on a biochemical or cellular level. An exam-
ple of combined GM events in the ﬁrst category is provided by
combining herbicide tolerance (e.g., from CP4 EPSPS protein
expression) and insect protection (e.g., from CRY1Ab protein
expression). An example of combined GM events in the second
category is multiple insect protection through the expression of
two different CRY proteins with speciﬁc molecular targets to pro-
tect against both coleopteran (via CRY3Bb protein expression)
and lepidopteran pests (via CRY1Ab protein expression). Based
Table 2
Guidance from international groups and agencies on combined GM events and conventional breeding.
Group or Agency Guidance
World Health Organization (WHO, 1995) ‘‘Progeny derived from food varieties shown to be substantially equivalent would be expected themselves to be
substantially equivalent. Traditional breeding practices would be expected to reject any varieties in which the
inserted trait is unstable or gives rise to adverse secondary effects.’’
‘‘. . .it is likely that additional varieties will be developed by crossing varieties, each of which was obtained by
genetic engineering. For example, if substantial equivalence has been demonstrated both for a tomato with a
gene producing a delayed ripening phenotype and for a tomato with a gene for herbicide resistance, then
crossing these two varieties would result in a new variety that would be expected to be substantially equivalent
to the parents.’’
Food and Agriculture Organization/World Health
Organization (FAO/WHO, 1996)
‘‘Further strains/varieties may be derived from genetically modiﬁed organisms by conventional techniques,
such as traditional. . .plant breeding. Where the genetically modiﬁed organisms have been determined to be
acceptable as a result of the safety assessment, these further strains/varieties should be assessed on their own
merits according to practices applied for the assessment of conventionally-derived organisms.’’
International Seed Federation (ISF, 2005) ‘‘Once a new transformation event has been determined by a recognized authority to be safe for human or
animal health and the environment then plants containing it should be useable in further plant breeding and
any progeny containing the same transformation event should be covered by the original commercialization
approval.’’
Crop Life International (CLI, 2005) ‘‘Combined trait plant biotechnology products produced by conventional plant breeding practices should be
subject to the same regulatory oversight that is applied to conventional crops produced using the same
techniques. Additional safety assessments should be conducted only when the traits are related, or where they
affect the same metabolic pathway.’’
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on the market do not interact.
3. Current regulatory situation for combined GM events
Currently, there is no global consensus for the regulation of pre-
viously approved GM events combined by conventional breeding.
For example, Codex (CODEX, 2003) provides internationally recog-
nized guidelines for conducting food safety assessments on single
GM events; however, these guidelines do not explicitly address
combined GM events generated through conventional breeding.
Consequently, individual regulatory agencies have devised their
own requirements (e.g., EFSA, 2007; CFIA, 2004; OGTR, 2007),
and requested data packages may range from minimal to exten-
sive. Table 1 identiﬁes those countries with no additional data
requirements for combined GM events that are unlikely to interact
and describes the continuum of additional data requirements and
complexity of review processes for other countries requiring com-
bined GM event review.
When assessing the safety of combined GM events, it is instruc-
tive to consider international guidance regarding conventional
breeding and substantial equivalence of GM events combined by
conventional breeding. For example, the World Health Organiza-
tion concludes that substantial equivalence should be maintained
in a combined GM trait variety if substantial equivalence had been
demonstrated for each of the parents. Speciﬁcally, they argue that
‘‘...if substantial equivalence has been demonstrated both for a
[genetically engineered] tomato with a gene producing a delayed
ripening phenotype and for a [genetically engineered] tomato with
a gene for herbicide resistance, then crossing these two varieties
would result in a new variety that would be expected to be sub-
stantially equivalent to the parents’’ (WHO, 1995). Additional
international groups, including the Food and Agriculture Organiza-
tion/World Health Organization (FAO/WHO, 1996), International
Seed Federation (ISF, 2005), and CropLife International (CLI,
2005) similarly advocate basing the safety of combined GM events
on the safety of the parental GM events (see Table 2).
Consistent with this international guidance, regulatory agencies
in some countries, including the US (FDA, 2001), Canada (CFIA,
2004), and Australia (OGTR, 2007), have requested no additional
regulatory data to approve combinedGMevents as long as the traits
are not likely to interact in amanner thatwould affect safety and the
risk assessments of the single events can reasonably be applied to
the combined event product. The FDA speciﬁcally states that ‘‘nar-row crosses are unlikely to result in unintended changes to foods
that raise safety or other regulatory questions’’ – ‘‘including narrow
crosses between different rDNA-modiﬁed [GM] lines’’ (FDA, 2001).
Contrary to this international guidance, somepropose that safety
testing beyond that required for the single GM events be conducted
for combinedGMevent product approvals (De Schrijver et al., 2007).
To support the regulatory approval of combined GM events, some
countries (i.e., those of the EU) have conducted complex reviews of
a comprehensive additional dataset as suggested by De Schrijver
et al. (2007), to document that combined GM event products are
no different from the parental single GM events from which they
were derived or their conventional counterparts. These additional
datamay include phenotypic characterization,molecular character-
ization, protein levels, morphology, and nutritional composition.
Other countries vary in the amount of data required to conﬁrm
that the single event assessments remain applicable to the com-
bined event (see Table 1). Many do not consider it necessary to re-
quire the development of a comprehensive dataset, or a complex
data review process, in order to conclude that the safety for the
combined GM event product has not changed. It is recognized that
the data generated for the parental single GM events can be used to
predict the safety of the combined GM event in most instances.
4. Safety considerations
4.1. Conventional plant breeding
The history of plant domestication and plant breeding dates
back approximately 10,000 years (McCouch, 2004). Plant breed-
ing has been practiced since early humans identiﬁed seeds from
the most productive plants and saved them to plant in the fol-
lowing growing season. The modern era of plant breeding, whose
beginning correlates with the rediscovery of Mendel’s work in
1900 (Duvick, 1996), has led to great success in combining desir-
able traits in a single crop as demonstrated by improved agro-
nomic, quality, and/or nutritional traits. These improvements
have been introduced using a variety of techniques, including
hybrid breeding, introgression of traits from wild relatives,
mutagenesis, wide crosses, embryo and ovule rescue, double
haploid technology, tissue culture and plant regeneration, and
protoplast fusion, all of which are considered routine applica-
tions of traditional plant breeding. More recently, molecular
marker technology has been employed to characterize progeny
and streamline the breeding process.
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and feed crops which exhibit familiar phenotypic and agronomic
properties in the environment. Many traits, including disease
resistance, yield, stress resistance, and quality/nutrition improve-
ments have been introgressed from wild species through con-
ventional plant breeding (Fernie et al., 2006; Hajjar and
Hodgkin, 2007). The process of identifying traits, combining
them in familiar genotypes to establish a history of safe use
(Constable et al., 2007) and selecting elite performing varieties
is routinely employed in plant breeding. Moreover, this approach
has an impressive record of food, feed, and environmental safety,
and rarely gives rise to safety concerns through unintended
effects (Cellini et al., 2004).
Combining multiple approved GM events using conventional
breeding to produce elite performing crops is increasingly impor-
tant in global agriculture (James, 2007; James, 2009). When con-
ventional breeding is used to generate varieties with combined
GM events, these varieties are screened over multiple generations
and across diverse growing environments. Typically, product per-
formance and agronomic features are evaluated and traits such
as yield, ﬁeld performance, and disease resistance are measured
and tested to ensure that the traits are stable, heritable, and ex-
press the desired phenotype under a wide range of environmental
conditions. The phenotypic characteristics evaluated during the
screening step are the expressed result of the plant’s genotype
and are the culmination of the complex metabolic pathways that
are activated in response to environmental conditions. Phenotypic
characteristics allow breeders to measure the degree to which
unintended effects are produced as a result of the various traits
combined in the variety. Selection during the conventional
breeding process is valuable in removing undesirable characteris-
tics and thereby helps to maintain the safety and quality of the
food and/or feed product (Cellini et al., 2004; NRC, 2004; WHO,
1995). Additional evaluations or analyses may be recommended
for a particular crop species that may contain a novel composi-
tional proﬁle or have an undesirable component (e.g., allergen, tox-
icant, or anti-nutrient) in a ﬁnal food or feed product at a level that
may be of concern. These components have been identiﬁed in var-
ious publications, for example OECD Consensus Documents (OECD,
2010). The requirements for these evaluations vary by crop and
country, most often based on variety registration requirements.
Breeders are aware of potential changes in composition that may
arise through breeding, and strict adherence to safe breeding prac-
tices and variety requirements ensure that food safety concerns are
unlikely to be repeated within the current disciplined
environment.
In summary, conventional breeding is widely and routinely
used to combine desirable traits in new crop varieties. Careful
attention to desired phenotype, progeny selection and phenotypic
performance of the resulting variety affords a signiﬁcant level of
risk management, thereby reducing the potential for harm to hu-
mans, animals, and the environment. With few exceptions, safe
food and feed products are generated from conventional plant
breeding. This approach has long been employed, and is based on
the underlying premise that newly generated varieties based on
existing crop varieties with a history of safe use are unlikely to pro-
duce unintended effects that would be a food safety concern. More
recently, the same modern plant breeding techniques used to com-
bine conventional traits have been used to combine GM traits pro-
duced through agricultural biotechnology.
4.2. Safety of crops with single GM events
Agricultural crops improved with a single GM event are rigor-
ously tested according to internationally recognized guidelines
(CODEX, 2003; SCBD, 2000) prior to regulatory approval and com-mercial availability. The development and commercialization of a
new GM event occurs through a lengthy and complicated process
that involves the following: (1) research to identify potentially
valuable genes, (2) product concept testing, (3) multiple transfor-
mations in model and target species, (4) screening to select the
best transformation event with the desired trait, (5) conventional
breeding into elite germplasm, followed by ﬁeld efﬁcacy testing,
(6) development of a scientiﬁcally robust safety data package, (7)
submission to, and evaluation and authorization by, regulatory
agencies, and (8) commercialization compliant with conditions of
the regulatory approval.
The regulatory review and authorization process for GM events
is more rigorous and extensive than for conventionally-bred crops
with similar modiﬁcations (Bradford et al., 2005; NRC, 2004). Konig
et al. (2004) noted that ‘‘It can even be argued that foods from GM
crops are better characterized than other non-regulated plant de-
rived foods, due to the additional rigour in the current regulatory
requirements and testing regime compared to that for convention-
ally-bred crops’’.
Before a GM event is commercialized, it must undergo a safety
review and be authorized by the relevant competent agencies un-
der all applicable regulations. The regulatory review routinely in-
cludes assessments for food, feed, and/or environmental safety
using a wide range of scientiﬁc studies that can be broadly grouped
into the following categories: event/molecular characterization;
trait expression/characterization; substantial equivalence; food/
feed safety; environmental safety; evaluations for plant incorpo-
rated protectants (PIP), if appropriate. Some speciﬁc studies for sin-
gle GM events are considered in greater detail below.
The regulatory data package developed for a single GM event
provides an in-depth analysis of the transformed plant, including
a description of the recipient plant, and a comprehensive molecu-
lar characterization of the introduced DNA that documents stabil-
ity and heritability over several generations. Multiple datasets are
available that consistently demonstrate the stable inheritance of
both the introduced DNA and the associated phenotype of single
GM events (Heck et al., 2005; Padgette et al., 1995). An important
aspect of product characterization is the stable inheritance of GM
events. Stable inheritance of the individual single GM events has
been recognized as sufﬁcient to assure the stability of these events
in the combined GM event product by FAO and WHO (FAO/WHO,
1991) and more recently by the UK’s Advisory Committee on Re-
leases to the Environment (ACRE, 2007). Therefore, use of the sin-
gle GM event assessment is appropriate to establish stable
inheritance in the combined GM event product.
Food and feed assessments are based on a full nutritional eval-
uation of the GM event grown in different environments that are
representative of normal cultivation conditions. Although not a
speciﬁc requirement under the Codex Guidelines (see paragraph
11, CODEX, 2003), an animal study is also provided. Such a study
may involve oral administration of high doses of puriﬁed protein
to investigate the toxicity of the protein or whole food animal feed-
ing with test animals such as rats or chickens to establish the nutri-
tional equivalence of the GM food compared to an equivalent
conventional feed. These evaluations, coupled with ﬁeld and agro-
nomic data, establish the safety of the introduced protein. They
also help to identify potential unintended effects from the genetic
modiﬁcation that may impact food safety, based on comparison to
existing crops or foods with a history of safe use (Cellini et al.,
2004; CODEX, 2003).
Single GM event crops with traits that derive from a newly
introduced protein (e.g., CRY or EPSPS proteins) are examined with
regard to protein structure, function, potential toxicity, and aller-
genicity of the introduced protein. The characteristics of the crop
and the potential environmental risk of releasing the GM event
are evaluated for a range of potential environmental effects. Spe-
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characteristics, effects on non-target organisms, gene ﬂow, poten-
tial increase in weediness or plant pest attributes, and stability un-
der a range of environmental conditions.
Codex Alimentarius incorporated data requirement guidelines
for the evaluation of GM products for food safety in 2003 (CODEX,
2003). Most countries requiring evaluation of GM products have
used these Codex guidelines as a framework to develop their
own food and feed safety data requirements. With respect to eval-
uating environmental risk, international guideline assessments are
contained within the Cartagena Protocol for Biosafety (SCBD,
2000). Even in those countries that have not ratiﬁed the Biosafety
Protocol, including the US, Canada, and Australia, similar principles
to evaluate environmental risk are used. The datasets described
above provide information that meets the requirements of these
international guidelines.
Because food and feed crops are traded internationally, the
safety of a GM event available in commerce has typically been re-
viewed and authorized by regulatory agencies in numerous coun-
tries. Currently, some form of regulatory review is required in the
ﬁfty-seven countries that have granted regulatory approvals for
GM crops (James, 2009). These include importing countries as well
as countries where the crop is cultivated. These multiple indepen-
dent regulatory approvals further document the safety of the GM
event.
In summary, single GM events are tested according to interna-
tional guidelines that are more rigorous and extensive than those
required for conventionally-bred crops with similar modiﬁcations.
Data submitted for regulatory review of single GM events supports
assessments for food, feed and environmental safety using a wide
range of scientiﬁc studies. Multiple datasets have demonstrated
the genomic and phenotypic stability and reviews by regulatory
agencies for ﬁfty-seven countries globally provide multiple conﬁr-
mations of the safety of the single GM event products.4.3. Safety of GM events combined by conventional breeding
Conventional plant breeding is routinely used to improve crop
performance and is speciﬁcally employed to develop plant varie-
ties that ﬁt particular environments and production practices
(Powell et al., 2003). Section 4.1 reviewed this process and consid-
ered its safe use in the development of food and feed products,
while the following Section 4.2 reviewed the rigorous safety
assessment process for single GM event products. The same biolog-
ical and selective principles used for conventional and single GM
event crop development are used to combine previously approved
GM events. Accordingly, single GM events previously assessed as
safe should be safe to combine through conventional plant breed-
ing when they are unlikely to interact in a manner affecting safety.
As a result, the rigorous safety assessments conducted on single
GM events, which were deemed to be as safe as their conventional
counterparts, also can be used to predict the safety of the com-
bined GM events.
There are many commercial examples of combined GM events,
and an updated list can be accessed through the Biosafety Clearing-
House (BCH, 2010). The safety of commercially available combined
GM events has been well-demonstrated in multiple independent
reports that document the continually increased acceptance and
use by farmers globally (Brooks and Barfoot, 2008; James, 2009;
Lemaux, 2008; Sankula, 2006). However, regulatory agencies in
some countries request additional characterization of combined
GM events and comparisons to single GM parental controls and
conventional comparators. These additional studies may include
analysis of phenotype, molecular characteristics, protein character-
istics, morphology and nutritional evaluation.It is instructive to look at the results of the additional safety
studies performed on combined GM events to consider if they con-
ﬁrm the safety anticipated from the same studies performed on the
single GM events. Analyses of combined GM events compared to
parental controls have consistently revealed the following: no phe-
notypic differences from parental events; molecular characteristics
that are the same as parental events with all events inherited sta-
bly; protein levels comparable to the single event parents; no mor-
phological differences compared to parental events; substantial
equivalence based on nutritional evaluation, with no pleiotropic
or toxic effects compared to the conventional non-GM crop. These
analyses are available on public websites, including those for the
US EPA (EPA, 2010), Japan Biosafety Clearing-House (JBCH, 2010)
and the EU (GMO Compass, 2010). In many cases, they also provide
the assessment conclusions of the appropriate competent authori-
ties providing the regulatory approval.
The results of the additional characterizations performed on the
current commercial combined event products, as described above,
provide scientiﬁc documentation that combining approved GM
events by conventional breeding has generated no unique safety
concerns. These results also demonstrate the general observation
that with respect to safety, the combined GM event product is no
different than either of the single GM event parents, and not sub-
stantially different from comparator conventional varieties. Specif-
ically, no substantiated safety concerns have been identiﬁed, nor
have any adverse effects been reported, for any approved commer-
cial combined GM event product.
In summary, the safety of combined GM event products is based
primarily on the use of a safe process, conventional plant breeding,
to combine single GM events that had previously been determined
to be safe through the regulatory review and approval process.
Thus, the data packages that had been developed for the single
GM events are useful in establishing the safety of the combined
event product. The results from the additional data that had been
submitted to countries that require them simply conﬁrm the safety
that would be expected from the use of a safe process to combine
products that had been previously determined to be safe.5. Discussion and recommendations
The use of GM crops is the most rapidly adopted crop technol-
ogy in the recent history of agriculture (James, 2008). The technol-
ogy has been embraced globally, and through 2009 GM maize,
cotton, soy, canola, sugar beet and alfalfa have been cultivated on
almost 1 billion hectares in 25 countries (James, 2009). GM crops
that obtained early commercial success provided single agronomic
traits (e.g., herbicide tolerance or insect protection), but generally
did not combine these beneﬁts in the same plant. The current
trend, to combine or ‘stack’ two or more single GM events, has pro-
vided growers with increased ﬂexibility and improved perfor-
mance. Combined trait crops are clearly preferred by growers in
the US, where, in 2009, more maize acres were planted with com-
bined GM products than the sum of conventional and single GM
event products (James, 2009). Not surprisingly, this trend toward
planting combined GM trait crops is becoming increasingly impor-
tant worldwide, where there is global pressure to increase crop
productivity to remain economically competitive and minimize
environmental impacts. Over a recent three year period, global
planting of combined GM trait crops increased from 11.6 million
hectares (11% of total) in 2006 to 28.7 million hectares (21% of to-
tal) in 2009 (James, 2007; James, 2009).
The data and information presented in previous sections de-
scribe the safety of conventional plant breeding (Section 4.1), the
regulatory review process that establishes the safety of single
GM events (Section 4.2), and the basis for the safety of combining
6 W. Pilacinski et al. / Food and Chemical Toxicology 49 (2011) 1–7GM events by conventional plant breeding (Section 4.3). Through a
review process far exceeding that employed for crops produced
through conventional breeding, the single GM event products have
already passed a rigorous regulatory safety review and have estab-
lished stability through conventional breeding. All this supports
the position that combining previously approved, single GM events
by conventional plant breeding produces combined GM event food
and feed products that are as safe as the parental GM single events
and their conventionally-produced counterparts. Therefore, it
seems reasonable to conclude that combined GM event crops gen-
erated through conventional breeding of single GM events warrant
little safety concern and regulatory requirements and procedures
for GM events combined through conventional breeding should re-
ﬂect the predicted safety established for the single GM events.
Thus, for events or traits unlikely to interact, the data on the single
GM events can be effectively ‘bridged’ to the combined GM event
product and the safety assessments performed on the single GM
event parents should be sufﬁcient to address any regulatory ques-
tions on the combined GM event product.
Given their expected safety, combined GM event crops pro-
duced through conventional breeding should be subject to little,
if any, regulatory data requirements beyond the safety assess-
ments and/or approvals of the single GM events. Thus, the regula-
tory approaches taken by those countries that do not require
additional data for combined GM events (i.e., US, Canada, Austra-
lia/New Zealand) are scientiﬁcally justiﬁed. For regulatory agencies
that desire conﬁrmatory information, data that demonstrate the
presence of the GM events and support lack of GM trait interac-
tions affecting safety or efﬁcacy of the product may be reasonable.
These data may include greenhouse or ﬁeld bioefﬁcacy studies,
gene or protein expression levels, and/or relevant composition
analyses on the combined GM event product. Additional studies
would be warranted if two or more of the traits present in the com-
bined GM event product are likely to interact in a manner that
would in some way change prior safety assessments. In this case,
appropriate experiments should be designed to address the antic-
ipated interaction. On the other hand, a request for extensive addi-
tional data, duplicating that developed for the single GM events,
does not appear to be scientiﬁcally justiﬁed for approved GM
events that are unlikely to interact as such data would be expected
to generate results that are equivalent to the results obtained for
the single GM event.
These recommendations assume previous or concurrent regula-
tory approval of single GM event products used to generate com-
bined GM event products. In terms of efﬁciency and appropriate
use of regulatory agency resources, the option of concurrent sub-
mission and review of data for the single GM event parents and
combined GM event products should be allowed.
The recommendations made here would maintain the rigorous
safety review process currently applied to GM events while allow-
ing efﬁcient use of limited regulatory agency resources. Careful
attention to a reasonable, science-based regulatory review process
will ensure the continued development and timely introduction of
new GM event varieties that are needed to sustain innovative plant
breeding to meet future agricultural demands.Conﬂict of Interest
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